Journal Report

Cardiovascular Endocrinology and Metabolism

Download PDF
Journal Information
Journal Title
Cardiovascular Endocrinology and Metabolism
Publisher
Lippincott Williams and Wilkins
ISSN
2574-0954
E-ISSN
Database
SCOPUS
Domain
Health Sciences, Life Sciences
Classification History
Year A+ A B C
2026 ✓
2025 ✓
2024 ✓
2023 ✓
2021/2022 ✓
2020 ✓
2019
2018
A journal may have more than one classification in the same year. All recorded classifications are displayed.
Recent Articles
Effect of glucagon-like peptide-1 receptor agonists on major adverse cardiovascular events in adults with type 2 diabetes and established atherosclerotic cardiovascular disease: systematic review and meta-analysis of randomised trials
Alejandro Montenegro-Avila, Abelardo Montenegro-Cantillo, Jheyson Fuentes et al.
2026-6-26 Vol. 15 Issue 3
DOI: 10.1097/xce.0000000000000360
Evaluating the cardio-protective effects of Momordica balsamina in a diet-induced prediabetic rats
Bongiwe Khumalo, Angezwa Siboto, Akinjide Moses Akinnuga et al.
2026-4-16 Vol. 15 Issue 2
DOI: 10.1097/xce.0000000000000359
Proteomics analysis of empagliflozin in patients without diabetes or overt heart failure from empagliflozin and cardiac remodeling in people without diabetes CardioLink-7 randomized clinical trial
Wei-Siang Chen, Ning-I Yang, Subodh Verma et al.
2026-4-13 Vol. 15 Issue 2
DOI: 10.1097/xce.0000000000000358
BRIDGE-DS study: a multicenter, observational, retrospective analysis of dapagliflozin and sitagliptin combination on modifiable cardiovascular risk factors in T2DM patients with ASCVD or high cardiovascular risk
Naveen Bhamri, Ashutosh Kumar, Chandrakant Mishra et al.
2025-9-18 Vol. 14 Issue 4
DOI: 10.1097/xce.0000000000000330
Glucagon-like peptide-1 receptor agonists and obesity paradox in heart failure with preserved ejection fraction: a systematic review
Darshan Hullon, Karolina Janiec, Violetta Florova et al.
2025-9-17 Vol. 14 Issue 4
DOI: 10.1097/xce.0000000000000344
Improved cardiovascular outcomes with glucagon-like peptide-1 receptor agonists – what is the role of weight reduction?
Stephan Jacob, Robert H. Eckel, Andrew J. Krentz
2025-9-11 Vol. 14 Issue 4
DOI: 10.1097/xce.0000000000000346
BRIDGE-DS study: evaluating the effectiveness and safety of dapagliflozin/sitagliptin combination in type 2 diabetes mellitus patients with heart failure
Kandanat Purushothaman Nair Suresh Kumar, Manikandan Thiruvanath Variam, Bala Vignesh S et al.
2025-9-3 Vol. 14 Issue 4
DOI: 10.1097/xce.0000000000000334
Genetic, neuropeptidergic, and cardiometabolic interplay in female central precocious puberty
Aygun Khaleddin Musayeva, Mahira Firudinkizi Amirova
2025-8-27 Vol. 14 Issue 3
DOI: 10.1097/xce.0000000000000343
Effects of obstructive sleep apnea on vascular structure and function in adults with obesity and type 2 diabetes: a comparative study
Kanpiraya Nithitsutthibuta, Nuntigar Sonsuwan, Sureeporn Uthaikhup et al.
2025-7-30 Vol. 14 Issue 3
DOI: 10.1097/xce.0000000000000342
Upregulation of miR-208a aggravates high-fat-diet induced cardiomyocyte injury by targeting insulin receptor substrate 2/phosphatidylinositol-3-kinases/protein kinase pathway
Ye Bi, Xin Zhao, Yao Wang et al.
2025-7-23 Vol. 14 Issue 3
DOI: 10.1097/xce.0000000000000340
Articles retrieved from Crossref.
Green Journals | https://www.green-journals.com | info@green-journals.com
Printed: November 11, 2026 01:48